On the effectiveness of odor-baited traps on mosquito-borne infections
Authors:
Haonan Zhong,
Marina Lima,
Andrea Pugliese,
Michela Sabbatino,
Cinzia Soresina,
Tamas Tekeli
Abstract:
The host's odor serves as a critical biological tracking signal in the host-seeking process of mosquitoes, and its heterogeneity significantly influences the transmission of mosquito-borne diseases. In this study, we propose a mosquito-borne disease model incorporating odor-baited traps to examine the impact of odor on disease transmission. Following recent experimental evidence, we also assume th…
▽ More
The host's odor serves as a critical biological tracking signal in the host-seeking process of mosquitoes, and its heterogeneity significantly influences the transmission of mosquito-borne diseases. In this study, we propose a mosquito-borne disease model incorporating odor-baited traps to examine the impact of odor on disease transmission. Following recent experimental evidence, we also assume that infected humans are more attractive than susceptible or recovered ones.
The value of the basic reproduction number, $R_0$, depends on the attractiveness of traps, adjusted relative to infected individuals; the dependence on the relative attractiveness of susceptibles is non-monotone, suggesting that there exists an optimal mosquito preference that maximizes disease transmission. When $R_0>1$, there exists an endemic equilibrium which, under certain conditions, is proved to be globally stable. An endemic equilibrium may also exist when $R_0 < 1$, due to a backward bifurcation occurring when infected humans incur significant mortality. The phenomenon of backward bifurcation is reduced when odor-baited traps are more abundant.
Analytical results and simulations show that deploying traps and enhancing their lethality for mosquitoes can help reduce disease prevalence and the risk of an outbreak. However, the attenuation of odor in highly attractive traps may lead to a rebound in the epidemic, especially when the traps gradually lose their attractiveness compared to susceptible hosts.
△ Less
Submitted 27 September, 2025;
originally announced September 2025.
What you saw is what you got? -- Correcting reported incidence data for testing intensity
Authors:
Rasmus Kristoffer Pedersen,
Christian Berrig,
Tamás Tekeli,
Gergely Röst,
Viggo Andreasen
Abstract:
During the COVID-19 pandemic, different types of non-pharmaceutical interventions played an important role in the efforts to control outbreaks and to limit the spread of the SARS-CoV-2 virus. In certain countries, large-scale voluntary testing of non-symptomatic individuals was done, with the aim of identifying asymptomatic and pre-symptomatic infections as well as gauging the prevalence in the ge…
▽ More
During the COVID-19 pandemic, different types of non-pharmaceutical interventions played an important role in the efforts to control outbreaks and to limit the spread of the SARS-CoV-2 virus. In certain countries, large-scale voluntary testing of non-symptomatic individuals was done, with the aim of identifying asymptomatic and pre-symptomatic infections as well as gauging the prevalence in the general population. In this work, we present a mathematical model, used to investigate the dynamics of both observed and unobserved infections as a function of the rate of voluntary testing. The model indicate that increasing the rate of testing causes the observed prevalence to increase, despite a decrease in the true prevalence. For large testing rates, the observed prevalence also decrease. The non-monotonicity of observed prevalence explains some of the discrepancies seen when comparing uncorrected case-counts between countries. An example of such discrepancy is the COVID-19 epidemics observed in Denmark and Hungary during winter 2020/2021, for which the reported case-counts were comparable but the true prevalence were very different. The model provides a quantitative measure for the ascertainment rate between observed and true incidence, allowing for test-intensity correction of incidence data. By comparing the model to the country-wide epidemic of the Omicron variant (BA.1 and BA.2) in Denmark during the winter 2021/2022, we find a good agreement between the cumulative incidence as estimated by the model and as suggested by serology-studies. While the model does not capture the full complexity of epidemic outbreaks and the effect of different interventions, it provides a simple way to correct raw case-counts for differences in voluntary testing, making comparison across international borders and testing behaviour possible.
△ Less
Submitted 9 September, 2024; v1 submitted 21 August, 2024;
originally announced August 2024.
